Due to the high diagnostic sensitivity of serum MALAT1 as a reference for NSCLC, the misdiagnosis rate of lung cancer is low, which indicates that serum MALAT1 has better clinical application value in lung cancer screening. Here, MALAT1 is linked to non-small cell lung carcinoma.